Abstract bekijken

Deze abstract is toegekend aan sessie AOB Free Papers 2
Type presentatieOral presentation
TitelRuthenium Brachytherapy in Uveal Melanoma
DoelReview of 136 uveal melanomas treated with ruthenium brachytherapy between 2019 and 2022. All tumors were treated with a top dosis of 100 Gy.
MethodesOf 167 irradiations with ruthenium brachytherapy, 136 were applicated for uveal melanomas. We performed a retrospective analysis of the patients, the complications, local recurrence, and survival. In comparison with the literature available for ruthenium brachytherapy in uveal melanomas. On this moment three different radioactive plaques are available in UZLeuven for different tumor sizes and localisations.
ResultatenOf 136 uveal melanomas, there were 3 patients with persistent vitreal hemorrahges, 1 patient with persistent diplopia the first 4 months, 8 with (amplification of their) serous detachments. One patient developed an orbital recurrence. Five patients died of melanoma during the follow-up. Three patients were re-treated because of local recurrence.
ConclusieRuthenium brachytherapy is a good and safe procedure for treatment of uveal melanomas.
BelangenverstrengelingNee
Auteur 1
NaamMISSOTTEN
InitialenG
InstituutUniversity Hospitals Leuven, Catholic University.
StadLeuven
Auteur 2
NaamChristiaens
InitialenM
InstituutUniversity Hospitals Leuven, Catholic University.
StadLeuven
Auteur 3
NaamClement
InitialenP
InstituutUniversity Hospitals Leuven, Catholic University
StadLeuven
Auteur 4
NaamVan Ginderdeuren
InitialenR
InstituutUniversity Hospitals Leuven, Catholic University
StadLeuven
Auteur 5
NaamVan Calster
InitialenJ
InstituutUniversity Hospitals Leuven, Leuven University
StadLeuven
top ^